Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.345 EUR | -1.47% | -1.88% | -15.16% |
Sales 2023 * | 21.51M 23M 31.44M | Sales 2024 * | 27.32M 29.21M 39.93M | Capitalization | 168M 180M 246M |
---|---|---|---|---|---|
Net income 2023 * | -69M -73.78M -101M | Net income 2024 * | -69M -73.78M -101M | EV / Sales 2023 * | 4.36 x |
Net cash position 2023 * | 74.53M 79.69M 109M | Net cash position 2024 * | 18.69M 19.98M 27.32M | EV / Sales 2024 * | 5.48 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 234 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 100% |
Latest transcript on Cellectis S.A.
1 day | -1.47% | ||
1 week | -1.88% | ||
Current month | -5.75% | ||
1 month | +2.85% | ||
3 months | -11.51% | ||
6 months | +157.41% | ||
Current year | -15.16% |
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Bing C. Wang
DFI | Director of Finance/CFO | 47 | 22-02-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.345 | -1.47% | 45,065 |
24-04-25 | 2.38 | -1.04% | 18,491 |
24-04-24 | 2.405 | -0.62% | 19,554 |
24-04-23 | 2.42 | -1.43% | 55,187 |
24-04-22 | 2.455 | +2.72% | 43,945 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.16% | 180M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALCLS Stock